Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187


Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.

Moreno J, Krishnan AV, Swami S, Nonn L, Peehl DM, Feldman D.

Cancer Res. 2005 Sep 1;65(17):7917-25.


Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.

Moreno J, Krishnan AV, Peehl DM, Feldman D.

Anticancer Res. 2006 Jul-Aug;26(4A):2525-30. Review.


Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.

Krishnan AV, Feldman D.

Endocr Relat Cancer. 2010 Jan 29;17(1):R19-38. doi: 10.1677/ERC-09-0139. Print 2010 Mar. Review.


Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity.

Krishnan AV, Moreno J, Nonn L, Swami S, Peehl DM, Feldman D.

J Bone Miner Res. 2007 Dec;22 Suppl 2:V74-80. doi: 10.1359/jbmr.07s213. Review.


Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients.

Swami S, Krishnan AV, Moreno J, Bhattacharyya RS, Gardner C, Brooks JD, Peehl DM, Feldman D.

Int J Cancer. 2009 May 1;124(9):2050-9. doi: 10.1002/ijc.24161.


Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.

Zha S, Gage WR, Sauvageot J, Saria EA, Putzi MJ, Ewing CM, Faith DA, Nelson WG, De Marzo AM, Isaacs WB.

Cancer Res. 2001 Dec 15;61(24):8617-23.


The role of cyclooxygenase-2 inhibition for the prevention and treatment of prostate carcinoma.

Lin DW, Nelson PS.

Clin Prostate Cancer. 2003 Sep;2(2):119-26.


Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer.

Moreno J, Krishnan AV, Feldman D.

J Steroid Biochem Mol Biol. 2005 Oct;97(1-2):31-6. Epub 2005 Jul 15. Review.


Nonsteroidal anti-inflammatory drugs may prevent colon cancer through suppression of hepatocyte growth factor expression.

Ota S, Tanaka Y, Bamba H, Kato A, Matsuzaki F.

Eur J Pharmacol. 1999 Feb 12;367(1):131-8.


Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells.

Tjandrawinata RR, Dahiya R, Hughes-Fulford M.

Br J Cancer. 1997;75(8):1111-8.


Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.

Lincová E, Hampl A, Pernicová Z, Starsíchová A, Krcmár P, Machala M, Kozubík A, Soucek K.

Biochem Pharmacol. 2009 Sep 15;78(6):561-72. doi: 10.1016/j.bcp.2009.05.001. Epub 2009 May 9.


Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer.

Krishnan AV, Moreno J, Nonn L, Malloy P, Swami S, Peng L, Peehl DM, Feldman D.

J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):694-702. Epub 2007 Jan 16.


Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.

Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N.

Clin Cancer Res. 2005 Sep 15;11(18):6738-44.


Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.

Davis JN, McCabe MT, Hayward SW, Park JM, Day ML.

Cancer Res. 2005 May 1;65(9):3633-42.


1,25-dihydroxyvitamin D3 induces NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human neonatal monocytes.

Pichaud F, Roux S, Frendo JL, Delage-Mourroux R, Maclouf J, de Vernejoul MC, Moukhtar MS, Jullienne A.

Blood. 1997 Mar 15;89(6):2105-12.


Evolution of the androgen receptor pathway during progression of prostate cancer.

Hendriksen PJ, Dits NF, Kokame K, Veldhoven A, van Weerden WM, Bangma CH, Trapman J, Jenster G.

Cancer Res. 2006 May 15;66(10):5012-20.


Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase.

Wakimoto N, Wolf I, Yin D, O'Kelly J, Akagi T, Abramovitz L, Black KL, Tai HH, Koeffler HP.

Cancer Res. 2008 Sep 1;68(17):6978-86. doi: 10.1158/0008-5472.CAN-07-5675.


Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.

Golovko O, Nazarova N, Tuohimaa P.

Life Sci. 2005 Jun 17;77(5):562-77. Epub 2005 Feb 25.


Supplemental Content

Support Center